Literature DB >> 18243585

A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification.

Valerie A Gruber1, Kevin L Delucchi, Anousheh Kielstein, Steven L Batki.   

Abstract

BACKGROUND: Important questions remain regarding the necessary duration and intensity for methadone treatment to be effective.
METHODS: As part of a clinical trial of tuberculosis chemoprophylaxis [Batki, S.L., Gruber, V.A., Bradley, J.M., Bradley, M., Delucchi, K., 2002. A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users. Drug Alcohol Depend. 66 283-293. doi:10.1016/S0376-8716(01)00208-3], patients with opioid dependence were recruited from an outpatient 21-day methadone detoxification program and were randomly assigned to one of three treatment conditions: (1) continuation in 21-day methadone detoxification; (2) transfer to 6-month methadone maintenance with only minimal counseling; or (3) transfer to 6-month methadone maintenance with standard twice monthly counseling and as-needed social work and psychiatric services. Both the 6-month maintenance treatments were followed by 1.5 months of detoxification. Urine drug tests and self-report measures were collected at baseline, months 1-6, and month 8.5.
RESULTS: Compared to 21-day methadone detoxification, 6-month methadone maintenance with either minimal or standard counseling resulted in fewer opiate positive urine tests and days of self-reported heroin and alcohol use. There was no change in cocaine use or other outcome measures. The increased counseling available in the standard counseling condition did not appear to reduce heroin use further than the minimal counseling condition, in contrast to the effect found for more structured counseling in long-term methadone maintenance (McLellan et al., 1993).
CONCLUSIONS: Six months of methadone maintenance, even with minimal counseling, reduces heroin and alcohol use more than 21-day methadone detoxification.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18243585      PMCID: PMC2821580          DOI: 10.1016/j.drugalcdep.2007.11.021

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  24 in total

1.  Identifying methadone maintenance clients at risk for poor treatment response: pretreatment and early progress indicators.

Authors:  A R Morral; M A Belding; M Y Iguchi
Journal:  Drug Alcohol Depend       Date:  1999-06-01       Impact factor: 4.492

2.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

3.  A randomized trial of an interim methadone maintenance clinic.

Authors:  S R Yancovitz; D C Des Jarlais; N P Peyser; E Drew; P Friedmann; H L Trigg; J W Robinson
Journal:  Am J Public Health       Date:  1991-09       Impact factor: 9.308

4.  Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial.

Authors:  E C Strain; G E Bigelow; I A Liebson; M L Stitzer
Journal:  JAMA       Date:  1999-03-17       Impact factor: 56.272

5.  Dose-response effects of methadone in the treatment of opioid dependence.

Authors:  E C Strain; M L Stitzer; I A Liebson; G E Bigelow
Journal:  Ann Intern Med       Date:  1993-07-01       Impact factor: 25.391

6.  The Fifth Edition of the Addiction Severity Index.

Authors:  A T McLellan; H Kushner; D Metzger; R Peters; I Smith; G Grissom; H Pettinati; M Argeriou
Journal:  J Subst Abuse Treat       Date:  1992

Review 7.  Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction.

Authors: 
Journal:  JAMA       Date:  1998-12-09       Impact factor: 56.272

8.  The effects of psychosocial services in substance abuse treatment.

Authors:  A T McLellan; I O Arndt; D S Metzger; G E Woody; C P O'Brien
Journal:  JAMA       Date:  1993-04-21       Impact factor: 56.272

9.  A new measure of substance abuse treatment. Initial studies of the treatment services review.

Authors:  A T McLellan; A I Alterman; J Cacciola; D Metzger; C P O'Brien
Journal:  J Nerv Ment Dis       Date:  1992-02       Impact factor: 2.254

10.  Behavioral treatment of cocaine-dependent pregnant women and TB-exposed patients.

Authors:  R Elk; J Schmitz; R Spiga; H Rhoades; R Andres; J Grabowski
Journal:  Addict Behav       Date:  1995 Jul-Aug       Impact factor: 3.913

View more
  41 in total

1.  Interim treatment: Bridging delays to opioid treatment access.

Authors:  Stacey C Sigmon
Journal:  Prev Med       Date:  2015-04-30       Impact factor: 4.018

2.  The impact of financial discharge from methadone maintenance therapy on incarceration.

Authors:  Nickolas D Zaller; Jeannia J Fu; Alexander R Bazazi; Josiah D Rich
Journal:  J Opioid Manag       Date:  2010 Sep-Oct

3.  Forced withdrawal from methadone maintenance therapy in criminal justice settings: a critical treatment barrier in the United States.

Authors:  Jeannia J Fu; Nickolas D Zaller; Michael A Yokell; Alexander R Bazazi; Josiah D Rich
Journal:  J Subst Abuse Treat       Date:  2013-02-22

4.  A stage I pilot study of acceptance and commitment therapy for methadone detoxification.

Authors:  Angela L Stotts; Charles Green; Akihiko Masuda; John Grabowski; Kelly Wilson; Thomas F Northrup; F Gerard Moeller; Joy M Schmitz
Journal:  Drug Alcohol Depend       Date:  2012-03-15       Impact factor: 4.492

5.  Functional imaging of emotion reactivity in opiate-dependent borderline personality disorder.

Authors:  Moria J Smoski; Nicholas Salsman; Lihong Wang; Veronica Smith; Thomas R Lynch; Stephen R Dager; Kevin S LaBar; Marsha M Linehan
Journal:  Personal Disord       Date:  2011-07

Review 6.  The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review.

Authors:  Kathleen M Carroll; Roger D Weiss
Journal:  Am J Psychiatry       Date:  2016-12-16       Impact factor: 18.112

Review 7.  Methadone at tapered doses for the management of opioid withdrawal.

Authors:  Laura Amato; Marina Davoli; Silvia Minozzi; Eliana Ferroni; Robert Ali; Marica Ferri
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

8.  Interim methadone treatment: impact on arrests.

Authors:  Robert P Schwartz; Jerome H Jaffe; Kevin E O'Grady; Timothy W Kinlock; Michael S Gordon; Sharon M Kelly; Monique E Wilson; Ashraf Ahmed
Journal:  Drug Alcohol Depend       Date:  2009-05-14       Impact factor: 4.492

9.  Bridging waitlist delays with interim buprenorphine treatment: initial feasibility.

Authors:  Stacey C Sigmon; Andrew C Meyer; Bryce Hruska; Taylor Ochalek; Gail Rose; Gary J Badger; John R Brooklyn; Sarah H Heil; Stephen T Higgins; Brent A Moore; Robert P Schwartz
Journal:  Addict Behav       Date:  2015-07-29       Impact factor: 3.913

10.  Interim versus standard methadone treatment: a benefit-cost analysis.

Authors:  Robert P Schwartz; Pierre K Alexandre; Sharon M Kelly; Kevin E O'Grady; Jan Gryczynski; Jerome H Jaffe
Journal:  J Subst Abuse Treat       Date:  2013-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.